GSA has teamed-up with several other organizations to address the challenges presented by the bacterium Clostridioides difficile — or C. difficile as it’s commonly abbreviated. Over the past year, I have had the privilege of representing GSA on the Steering Committee of the C. difficile Awareness Initiative, which was formed in response to the Centers for Disease Control and Prevention deeming this infectious disease an urgent public health threat.

When the pandemic unfolded last year, my admiration for the GSA membership was once again reaffirmed when our newly formed GSA COVID-19 Task Force and existing National Adult Vaccination Program Workgroup began rolling out an impressive array of resources to help all of us make sense of emerging information about COVID-19 and its impact on older adults. And it’s important to know their work is continuing, and updates have been made to existing tools as we gain new knowledge, particularly in the area of vaccines.